Publication | Closed Access
Comparison of the Ocular Hypotensive Lipid AGN 192024 With Timolol
58
Citations
14
References
2001
Year
Of the 3 concentrations tested, 0.03% AGN 192024 once daily had the best therapeutic profile. AGN 192024 was safe and well tolerated, and it provided superior ocular hypotensive efficacy and diurnal IOP control compared with timolol in patients with ocular hypertension and glaucoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1